Synchronous colorectal neoplasias: our experience about laparoscopic-TEM combined treatment

World Journal of Surgical Oncology

Research

Maurizio Bravetti¹  Roberto Cirocchi¹  Micol Sole Di Patrizi¹  Angelo De Sol¹  Marco Coccetta¹  Eleonora Pressi¹  Francesco La Mura¹  Daniele Giuliani¹  Vincenzo Napolitano¹  Alessandro Spizzirri¹  Francesco Sciannameo¹  Stefano Trastulli¹  Nicola Avenia² 

[1] General Surgery Department, St. Maria Hospital, University of Perugia, Terni, (TR), Italy;Head and Neck Surgery Department, St Maria Hospital, University of Perugia, Terni, (TR), Italy;

关键词: Adenoma;    Anterior Resection;    Transanal Endoscopic Microsurgery;    Neoplastic Lesion;    Laparoscopic Colectomy;   

DOI  :  10.1186/1477-7819-8-105

 received in 2009-03-01, accepted in 2010-11-25,  发布年份 2010

来源: Springer

【 摘 要 】

Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time. The most voluminous synchronous cancer is called "first primitive" or "index" cancer. The aim of this work is to describe our experience of minimally invasive approach in patients with synchronous colorectal neoplasias.Since January 2001 till December 2009, 557 patients underwent colectomy for colorectal cancer at the Department of General and Emergency Surgery of the University of Perugia; 128 were right colon cancers, 195 were left colon cancers while 234 patients were affected by rectal cancers. We performed 224 laparoscopic colectomies (112 right, 67 left colectomies and 45 anterior resections of rectum), 91 Transanal Endoscopic Microsurgical Excisions (TEM) and 53 Trans Anal Excisions (TAE). In the same observation period 6 patients, 4 males and 2 females, were diagnosed with synchronous colorectal neoplasias. Minimal invasive treatment of colorectal cancer offers the opportunity to treat two different neoplastic lesions at the same time, with a shorter post-operative hospitalization and minor complications. According to our experience, laparoscopy and TEM may ease the treatment of synchronous diseases with a lower morbidity rate.

【 授权许可】

CC BY   
© Spizzirri et al; licensee BioMed Central Ltd. 2010